As cfDNA is tumor derived and carries cancer-specific genetic and epigenetic aberrations (28, 39), we then observed the DLX6-AS1 hypermethylation in the cfDNA samples from CRC patients as compared to healthy controls. This evidence concerns the gene DLX6 and colorectal carcinoma.